Arbutus Biopharma Corp (NASDAQ:ABUS)

1.93
Delayed Data
As of Sep 23
 -0.03 / -1.53%
Today’s Change
1.85
Today|||52-Week Range
6.50
-50.39%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 6.00, with a high estimate of 9.00 and a low estimate of 4.00. The median estimate represents a +210.88% increase from the last price of 1.93.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$9.4M
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.00%
 
 
 
 
 
 
Growthannually 45.06%
 
 
 
 
 
 

Sales

Growthquarterly -34.18%
 
 
 
 
 
 
Growthannually 308.63%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.